Education
About Us
Working with TipRanks
Follow Us
VentriPoint Diagnostics Ltd (TSE:VPT)
:VPT
RESEARCH TOOLSreports
VPT Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.08 - C$0.26
Previous CloseN/A
Volume32.00K
Average Volume (3M)100.66K
Market Cap
C$22.01M
Enterprise ValueC$23.34M
Total Cash (Recent Filing)C$110.69K
Total Debt (Recent Filing)C$1.44M
Price to Earnings (P/E)―
Beta-0.03
Next Earnings
Jun 03, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding163,057,280
10 Day Avg. Volume133,160
30 Day Avg. Volume100,656
Financial Highlights & Ratios
PEG Ratio3.34
Price to Book (P/B)-8.64
Price to Sales (P/S)0.00
P/FCF Ratio-6.02
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
VentriPoint Diagnostics News
PremiumCompany Announcements
Ventripoint Strengthens Advisory Board with AI Executive for Global Expansion
PremiumCompany Announcements
Ventripoint Diagnostics Advances Cardiac Solutions with VMS+ v4.0
PremiumCompany Announcements
Ventripoint Diagnostics Strengthens Clinical Leadership with New Appointment
PremiumCompany Announcements
Ventripoint Seeks Extension for Warrant Expiry
PremiumCompany Announcements
Ventripoint Diagnostics Unveils AI-Enhanced Cardiac Imaging WhitepaperPremiumCompany Announcements
Ventripoint Diagnostics Secures $500,000 in Private PlacementPremiumCompany Announcements
VentriPoint Diagnostics Launches Private Placement to Bolster Operations
PremiumCompany Announcements
Ventripoint Diagnostics Secures FDA Clearance for VMS+ 4.0---
Options Prices
Currently, No data available
---
Ownership Overview
2.67% Insiders
―
Mutual Funds
― Other Institutional Investors
97.33% Public Companies and
Individual Investors
VPT FAQ
What was VentriPoint Diagnostics Ltd’s price range in the past 12 months?
VentriPoint Diagnostics Ltd lowest stock price was C$0.07 and its highest was C$0.26 in the past 12 months.
What is VentriPoint Diagnostics Ltd’s market cap?
VentriPoint Diagnostics Ltd’s market cap is C$22.01M.
When is VentriPoint Diagnostics Ltd’s upcoming earnings report date?
VentriPoint Diagnostics Ltd’s upcoming earnings report date is Jun 03, 2025 which is in 20 days.
How were VentriPoint Diagnostics Ltd’s earnings last quarter?
Currently, no data Available
Is VentriPoint Diagnostics Ltd overvalued?
According to Wall Street analysts VentriPoint Diagnostics Ltd’s price is currently Overvalued.
Does VentriPoint Diagnostics Ltd pay dividends?
VentriPoint Diagnostics Ltd does not currently pay dividends.
What is VentriPoint Diagnostics Ltd’s EPS estimate?
VentriPoint Diagnostics Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does VentriPoint Diagnostics Ltd have?
VentriPoint Diagnostics Ltd has 163,057,280 shares outstanding.
What happened to VentriPoint Diagnostics Ltd’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of VentriPoint Diagnostics Ltd?
Currently, no hedge funds are holding shares in TSE:VPT
---
VentriPoint Diagnostics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Sold Shares
Worth C$3.2K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-44.89%
12-Months-Change
Fundamentals
Return on Equity
207.08%
Trailing 12-Months
Asset Growth
-65.06%
Trailing 12-Months
Company Description
VentriPoint Diagnostics Ltd
Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model of the heart chamber using echocardiograms and magnetic resonance imaging images; and obtain reproducible, accurate volumetric measurement, and ejection fraction. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity in oncology patients, and Covid-19 related heart issues. The company was incorporated in 2004 and is based in Toronto, Canada.
---
Technical Analysis
Aurora Spine
―
Perimeter Medical Imaging AI
―
Quipt Home Medical
―
Profound Medical
―
Theralase Technologies
―
---